feed,title,long_url,short_url
InsiderMonkey,Jim Cramer Prefers GE Vernova Over NuScale Power Corporation (SMR),https://insidermonkey.com/blog/--1544587,
InsiderMonkey,"Jim Cramer on Leidos Holdings, Inc. (LDOS): “I Think It’s a Good Opportunity”",https://insidermonkey.com/blog/--1544590,
InsiderMonkey,Jim Cramer Thinks Lululemon Athletica Inc. (LULU) “Can Continue Making a Comeback”,https://insidermonkey.com/blog/--1544595,
InsiderMonkey,"Jim Cramer on Interactive Brokers Group, Inc. (IBKR): “I Say Buy”",https://insidermonkey.com/blog/--1544596,
InsiderMonkey,Jim Cramer Says “I Want You to Buy Reddit (RDDT) Here”,https://insidermonkey.com/blog/--1544597,
InsiderMonkey,Jim Cramer Says to Wait “Before You Pull the Trigger” on Chevron Corporation (CVX) Stock,https://insidermonkey.com/blog/--1544593,
InsiderMonkey,Jim Cramer Says “Costco (COST) is Actually on Fire”,https://insidermonkey.com/blog/--1544594,
InsiderMonkey,Jim Cramer Thinks GE Vernova (GEV) is the Only Company “Ready to Profit From New Nuclear Reactors”,https://insidermonkey.com/blog/--1544588,
InsiderMonkey,Goldman Sachs Analyst Reinstates Sell Rating on DBV Technologies Amid VP Treatment Risks,https://insidermonkey.com/blog/--1543698,
InsiderMonkey,Barclays Initiates Coverage of Sun Communities (SUI) with Overweight Rating,https://insidermonkey.com/blog/--1543702,
InsiderMonkey,Wells Fargo Downgrades SentinelOne As Management Warns of ARR Slowdown,https://insidermonkey.com/blog/--1543676,
InsiderMonkey,Why These Energy Stocks are Gaining This Week,https://insidermonkey.com/blog/--1544196,
InsiderMonkey,"BofA Lifts Coherent Corporation’s (COHR) Price Target to $92.00, Keeps Buy Rating",https://insidermonkey.com/blog/--1544374,
InsiderMonkey,"Oppenheimer Slashes Price Target on Salesforce (CRM), Maintains an Outperform Rating",https://insidermonkey.com/blog/--1543509,
InsiderMonkey,Bernstein Maintains Underperform Rating on Salesforce (CRM),https://insidermonkey.com/blog/--1543510,
InsiderMonkey,Piper Sandler Reduces Prothena (PRTA) Price Target to $81 from $110 Following AFFIRM-AL Trial Discontinuation,https://insidermonkey.com/blog/--1541795,
InsiderMonkey,Chardan Lowers Prothena (PRTA) Price Target Following AFFIRM-AL Trial Failure,https://insidermonkey.com/blog/--1541794,
InsiderMonkey,"H.C. Wainwright Maintains Buy Rating on Prothena Corporation (NASDAQ:PRTA), Cuts PT",https://insidermonkey.com/blog/--1541796,
